See more from Burges Salmon
Want more Burges Salmon content? Add us as a preferred source on Google to your favourites list for content and news you can trust.
Update your preferred sourcesThis website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Last week, the European Parliament Committee on Internal Market and Consumer Protection (IMCO) published a draft opinion, which highlighted that AI applications could present challenges to the existing EU legal framework on product liability and called for further review by the European Parliament Committee on Legal Affairs (CLA).
In particular, the IMCO called on the CLA:
Any possible changes to the product liability regime would be of interest to software developers and vendors, who would be brought within scope. The EU Medical Devices Regulation - implementation of which was delayed for a year due to the impact of Covid-19 - has already included certain medical software into the definition of “medical devices”, which are subject to more stringent regulatory scrutiny.
The UK previously indicated that it would uphold its commitment to implement the MDR despite Brexit. Should the IMCO’s suggestions be adopted by CLA and the European Commission, the revised Product Liability Directive will become an important piece of regulation AI vendors and insurers will need to consider.
Want more Burges Salmon content? Add us as a preferred source on Google to your favourites list for content and news you can trust.
Update your preferred sourcesBe sure to follow us on LinkedIn and stay up to date with all the latest from Burges Salmon.
Follow us